- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Hyperion DeFi, Inc.(HYPD)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for HYPD
11/13/2026: HYPD (1-star) is currently NOT-A-BUY. Pass it for now.
Hyperion DeFi, Inc. is a digital asset treasury and decentralized finance operating company that provides public markets with exposure to the Hyperliquid ecosystem alongside legacy ophthalmic assets. The company's main strengths include a debt-free balance sheet, active capital optimization, and innovative DeFi yield generation strategies that outperform passive token holding. Its primary investment growth story centers on capturing high-growth decentralized finance infrastructure returns and scaling institutional credit facilities. Key risks involve high price volatility tied to digital asset markets, thin trading liquidity, and evolving regulatory frameworks surrounding cryptocurrency. The stock suits risk-tolerant growth investors seeking crypto-adjacent exposure while monitoring ongoing treasury execution and network adoption metrics.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit while signal remains positive | The company offers direct exposure to high-growth decentralized finance trends and scaling blockchain infrastructure. |
| Momentum investor | Strong fit while signal remains positive | Stock price action tracks digital asset volatility closely, creating potential momentum-driven trading windows. |
| Value investor | Weak fit | Valuation relies heavily on digital asset market sentiment rather than traditional discounted cash flow metrics. |
| Dividend investor | Weak fit | The company does not pay dividends, directing cash flow into growth and treasury accumulation. |
| Low-risk investor | Weak fit | Substantial price volatility and exposure to digital asset markets introduce high risk profiles. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Shares experience sharp fluctuations driven by cryptocurrency market sentiment and token price swings. |
| Valuation risk | Medium / high | Valuation models depend heavily on the fluctuating net asset value of digital treasury holdings. |
| Competition risk (digital asset treasury & DeFi competition) | Medium | The firm competes with alternative digital asset investment vehicles and crypto-holding operating entities. |
| Business quality | Medium | The operating model is novel and transitioning rapidly from its historical biotechnology roots. |
| Dividend income | Low / none | No dividend yield is offered to investors seeking recurring income. |
| Execution risk | Medium / high | Success depends on effective management of decentralized finance strategies and blockchain infrastructure. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 39.84M USD | Price to earnings Ratio - | 1Y Target Price 9.82 |
Price to earnings Ratio - | 1Y Target Price 9.82 | ||
Volume (30-day avg) 259.3K shares | Beta 2.74 | 52 Weeks Range 2.34 - 5.14 | Updated Date 11/15/2026 |
52 Weeks Range 2.34 - 5.14 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -6.46 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Biotechnology
- BUY participation
- 45.5%
- Active BUY / eligible
- 20 / 44
- 30-Day BUY Count Change
- +13
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Downtrend
The stock has experienced a sustained decline in price over recent periods.

Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit -57.9% | Avg. Invested days 13 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Digital Assets & DeFi Operations | Staking rewards, validator operations, ecosystem yield generation, and institutional credit facilities tied to the Hyperliquid blockchain. | Generates revenue through active participation in decentralized finance ecosystems rather than traditional product sales. |
| Ophthalmic Technology | Legacy development and licensing of ophthalmic drug delivery systems like the Optejet device. | Represents a legacy healthcare segment with potential milestone or licensing upside. |
Earnings Date
Report Date 2026-11-12 | When Before Market | Estimate 2.31 | Actual 1.23 |
Profitability
Profit Margin 474.87% | Operating Margin (TTM) -1066.76% |
Management Effectiveness
Return on Assets (TTM) -11.06% | Return on Equity (TTM) 9.55% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 39.12M | Price to Sales(TTM) 28.44 |
Enterprise Value 39.12M | Price to Sales(TTM) 28.44 | ||
Enterprise Value to Revenue 27.93 | Enterprise Value to EBITDA 5.17 | Shares Outstanding 15.44M | Shares Floating 13.75M |
Shares Outstanding 15.44M | Shares Floating 13.75M | ||
Percent Insiders 5.33 | Percent Institutions 19.75 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

